HedgePath Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$27.04 M |
Shares Outstanding |
370.45 M |
Public Float |
77.3 M |
Address |
4830 West Kennedy Boulevard Tampa Florida 33609 United States |
Employees | - |
Website | http://www.hedgepathpharma.com |
Updated | 07/08/2019 |
HedgePath Pharmaceuticals, Inc. is clinical stage biopharmaceutical company, which discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. It also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL. |